Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors-Reference-Cited by-同舟云学术

Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors

Published:2018-06-14 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Hammond Edward,Haynes Nicole M.,Cullinane Carleen,Brennan Todd V.,Bampton Darryn,Handley Paul,Karoli Tomislav,Lanksheer Fleur,Lin Liwen,Yang Yiping,Dredge Keith^ORCID

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0363-5.pdf

Reference51 articles.

1. Dredge K, Hammond E, Davis K, Li CP, Liu L, Johnstone K, et al. The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy. Investig New Drugs. 2010;28:276–83. https://doi.org/10.1007/s10637-009-9245-5 .

2. Ferro V, Liu L, Johnstone KD, Wimmer N, Karoli T, Handley P, et al. Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. J Med Chem. 2012;55:3804–13. https://doi.org/10.1021/jm201708h .

3. Hammond E, Handley P, Dredge K, Bytheway I. Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues. FEBS Open Bio. 2013;3:346–51. https://doi.org/10.1016/j.fob.2013.07.007 .

4. Vlodavsky I, Singh P, Boyango I, Gutter-Kapon L, Elkin M, Sanderson RD, et al. Heparanase: from basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat. 2016;29:54–75. https://doi.org/10.1016/j.drup.2016.10.001 .

5. Zhang Y-F, Tang X-D, Gao J-H, Fang D-C, Yang S-M. Heparanase: a universal immunotherapeutic target in human cancers. Drug Discov Today. 2011;16:412–7. https://doi.org/10.1016/j.drudis.2011.02.015 .

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycosaminoglycan microarrays for studying glycosaminoglycan–protein systems;Carbohydrate Polymers;2024-07

2. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes;Cardiovascular Diabetology;2024-02-01

3. MyD88 signaling pathways: role in breast cancer;Frontiers in Oncology;2024-01-29

4. Non-Anticoagulant Activities of Low Molecular Weight Heparins—A Review;Pharmaceuticals;2023-09-05

5. PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction;Oncogene;2023-08-07